Advertisement

Reactions Weekly

, Volume 1746, Issue 1, pp 11–11 | Cite as

Quetiapine ER vs aripiprazole in youths: cardiometabolic effects

Clinical study
  • 45 Downloads

Reference

  1. Jensen KG, et al. Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial. Journal of the American Academy of Child and Adolescent Psychiatry : 8 Mar 2019. Available from: URL: http://doi.org/10.1016/j.jaac.2019.01.015

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations